The England & Wales Court of Appeal has upheld Mr Justice Arnold's finding that key claims of Warner-Lambert's patent for Lyrica are invalid for insufficiency. The judgment also reiginites the debate over the scope of second medical use patents
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The latest round of promotions has contributed to a 21% rise in partner headcount in the past two years, with business leaders eyeing litigation and the UPC
Newly independent King & Wood has established offices in North America, while Mallesons has entered a ‘new era’ with a 1,200-lawyer firm across Australia and Singapore